Evidence map›Paper›PMID 20532699›Full record

ReviewCurrent hypertension reports2010

Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.

Michel Félétou, Ralf Köhler, Paul M Vanhoutte

Open access · hybridAbstract readReview
In one paragraph

Review in Current hypertension reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 161 citations in OpenAlex.

  1. Review
  2. Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-Journal of medicinal chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Do patients benefit from omega-3 fatty acids?Cardiovascular research · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Endothelial MicroRNA-483-3p Is Hypertension-Protective.Oxidative medicine and cellular longevity · 2022
    Article
  12. Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension.Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Article
  13. Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.International journal of environmental research and public health · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 4 countries.

Michel FélétouDepartment of Angiology, Institut de Recherches Servier, Suresnes, France.
Ralf Köhler
Paul M Vanhoutte
Jeonbuk National University · KRServier (France) · FRUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial cells regulate vascular tone by releasing various contracting and relaxing factors including nitric oxide (NO), arachidonic acid metabolites (derived from cyclooxygenases, lipoxygenases, and cytochrome P450 monooxygenases), reactive oxygen species, and vasoactive peptides. Additionally, another pathway associated with the hyperpolarization of the underlying smooth muscle cells plays a predominant role in resistance arteries. Endothelial dysfunction is a multifaceted disorder, which has been associated with hypertension of diverse etiologies, involving not only alterations of the L-arginine NO-synthase-soluble guanylyl cyclase pathway but also reduced endothelium-dependent hyperpolarizations and enhanced production of contracting factors, particularly vasoconstrictor prostanoids. This brief review highlights these different endothelial pathways as potential drug targets for novel treatments in hypertension and the associated endothelial dysfunction and end-organ damage.

Indexed as

Arachidonic AcidCalcium ChannelsEndothelium, VascularHumansHypertensionNitric OxideNitric Oxide SynthaseOxidative StressPotassium ChannelsProstaglandin-Endoperoxide SynthasesReactive Oxygen SpeciesArachidonic AcidCalcium ChannelsNitric OxideNitric Oxide SynthasePotassium ChannelsProstaglandin-Endoperoxide SynthasesReactive Oxygen Species

Identifiers

PMID20532699
PMCPMC2910890
OpenAlexW2072335766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.